You can help give men the clarity they deserve
Receiving a prostate cancer diagnosis is an overwhelming experience, and we know that starting treatment as early as possible is vital. This often means men have to make timely decisions about their treatment at the point of diagnosis, when they have limited information about the cancer and how it might develop.
Each man deserves to have a clear picture of their treatment options from the very start, so they can get the personalised treatment they deserve.
Will you help us bring the future into focus for men with prostate cancer?
Revolutionising prostate cancer diagnosis with AI
A team led by Professor Clare Verrill at the University of Oxford is exploring how artificial intelligence (AI) could improve prostate cancer diagnosis, to give men a clearer picture of their cancer from the outset.
The researchers are using a cutting-edge AI tool that can analyse men’s biopsy samples and identify microscopic details that the human eye can’t pick up. With the help of this AI technology, doctors would notice minor changes in the cancer cells that could help predict how aggressive the cancer could be and how it might develop.
Having access to this information at the early stage of diagnosis could give men a more detailed view of their cancer, as well as helping doctors give them the personalised treatment they need and deserve.
Prof Verrill’s study will be the first to introduce this AI tool – previously trialled in the US – in NHS hospitals, gathering crucial additional evidence to help men navigate prostate cancer diagnosis and treatment.
You can read more about Prof Verrill's research here.
Will you help give men the clear and accurate diagnosis they deserve?
This AI technology could provide a faster, more consistent way to decide who actually needs treatment. It could be a gamechanger.
Ian’s story
At 52 years old, Ian thought of prostate cancer as “an old man’s disease” and didn’t think it could affect younger, physically fit men like him. When he was unfortunately diagnosed with advanced prostate cancer, he was given limited options for his treatment.
Ian’s current hormone therapy, enzalutamide, is helping slow the spread of his cancer, but it’s also led to significant side effects. That’s why he wants to make sure other men get the most accurate and clear diagnosis as early as possible, to help them decide their treatment approach before their cancer reaches an advanced stage.
“Research like this gives me hope for the future. That men like me won’t be left in the dark when they get their diagnosis – and might not have to go through the experience I’ve had.” - Ian
By funding Prof Verrill’s research, you could give men a clearer view of their cancer from the point of diagnosis.
